Sharing Progress in Cancer Care

In the fitfth episode of our ‘Behind Every Drug There’s a Story’ series, our Scientific Clinical Advisor, Aleksandra Filipovic, sits down with Dr Azra Raza, Chan Soon-Shiong Professor of Medicine and Clinical Director, Edward P. Evans Foundation MDS Center Columbia University Medical Center.

In the fourth episode of our ‘Behind Every Drug There is a Story’ series, our Scientific Clinical Advisor, @Aleksandra Filipovic, sits down with Dr Steve Bierman, Director of the Noetic Medicine Initiative at the Andrew Weil Center for Integrative Medicine (University of Arizona).

Steve Bierman M.D., worked for 20 years as an Emergency Physician at Scripps Hospital in Encinitas, California. He holds over 200 patents on medical devices and other inventions, and is the founder of two medical device companies.

Recently, Dr Bierman published his groundbreaking book, “HEALING – Beyond Pills & Potions”.

In the third episode of our series, SPCC Scientific Clinical Advisor, Aleksandra Filipovic, sits down with Dr William Pao, a visionary physician-scientist whose career bridges academia, industry, and biotech innovation.

Dr Pao has made groundbreaking contributions to cancer research and treatment. From shaping the standard of care in lung cancer as a practicing oncologist, to leading drug discovery and development in executive roles at Roche and Pfizer, his work has impacted countless lives.

In the interview, Dr Pao dives into his newly published book “Breakthrough: The Quest for Life-changing Medicines”, sharing the remarkable stories behind the development of eight transformative medicines for cancer and other conditions. He celebrates the dedication of everyone involved in research science and drug development, offering a powerful tribute to the collaborative spirit that drives innovation.

In the second edition of our Behind every drug there is a story series, our Scientific Clinical Advisor, Aleksandra Filipovic, sits down with the renowned Prof. Tak Mak in an exclusive interview. Discover the life and extraordinary career of this pioneering scientist. Prof. Mak shares the story behind his groundbreaking discovery of the T-cell receptor, along with the lasting impact he continues to have on science and medicine.

Aleksandra Filipovic, Scientific Clinical Advisor at SPCC, recently interviewed Dr. Brian Druker, the esteemed director of the OHSU Knight Cancer Institute. Known for his groundbreaking work in cancer research, Dr. Druker developed Gleevec, a targeted therapy that revolutionised the treatment of chronic myeloid leukemia (CML) by attacking cancer cells while preserving healthy ones. In the interview, Dr. Druker also reflects on the key milestones of his life and career, from his early days to his present work.